Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided

Cerebrovascular Diseases

Volumn 23, Issue 4, 2007, Pages 294-298

  Boode, Bep ^a   Welzen, Vivian ^a   Franke, Cees ^c   Van Oostenbrugge, Robert ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

Doctor delay; Patient delay; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE;

ADULT; AGED; AROUSAL; ARTICLE; ASSAY; AWARENESS; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; STROKE PATIENT; THERAPY DELAY;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT SELECTION; PRACTICE GUIDELINES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRANSPORTATION OF PATIENTS;

EID: 33947216245     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098330     Document Type: Article

References (23)

1. Wardlaw JM, Del Zoppo G, Yamaguchi T, Berge E: Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003;3:CD000213.
2. Davalos A: Thrombolysis in acute ischemic stroke: success, failures and new hopes. Cerebrovasc Dis 2005;20(suppl 2):135-139.
3. Smith MA, Doliszny KM, Shahar E, McGovern PG, Arnett DK, Luepker RV: Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Ann Intern Med 1998;129:190-196.
4. Wester P, Radberg J, Lundgren B, Peltonen M: Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study. Seek-Medical-Attention-in-Time Study Group. Stroke 1999;30:40-48.
5. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S: Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke 2000;31:2585-2590.
6. Schroeder EB, Rosamond WD, Morris DL, Evenson KR, Hinn AR: Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke 2000;31:2591-2596.
7. Lacy CR, Suh DC, Bueno M, Kostis JB: Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32:63-69.
8. Evenson KR, Rosamond WD, Morris DL: Prehospital and in-hospital delays in acute stroke care. Neuroepidemiology 2001;20:65-76.
9. Goldstein LB, Edwards MG, Wood DP: Delay between stroke onset and emergency department evaluation. Neuroepidemiology 2001;3:196-200.
10. Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P: Factors influencing early admission in a French stroke unit. Stroke 2002;33:153-159.
11. Chang KC, Tseng MC, Tan TY: Prehospital delay after acute stroke in Kaohsiung, Taiwan. Stroke 2004;35:700-704.
12. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM: Cleveland Clinic Health System Stroke Quality Improvement Team. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004;61:346-350.
13. Schneider AT, Pancioli AM, Khoury JC, Rademacher E, Tuchfarber A, Miller R, Woo D, Kissela B, Broderick JP: Trends in community knowledge of the warning signs and risk factors for stroke. JAMA 2003;289:343-346.
14. Pancioli AM, Broderick J, Kothari R, Brott T, Tuchfarber A, Miller R, Khoury J, Jauch E: Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998;279:1288-1292.
15. Rossnagel K, Jungehülsing G, Nolte C, Müller-Nordhorn J, Roll S, Wegscheider K, Villringer A, Willich SN: Out-of-hospital delays in patients with acute stroke. Ann Emerg Med 2004;44:476-483.
16. Tanne D, Demchuk AM, Kasner SE: Intravenous thrombolysis for acute ischemic stroke: the phase IV data. J Stroke Cerebrovasc Dis 2002;11:137-147.
17. Walters MR, Muir KW, Harbison J, Lees KR, Ford GA: Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovasc Dis 2005;20:438-442.
18. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
19. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015-1020.
20. Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, Diaz-Manera J, Aleu A, Pagonabarraga J, Garcia-Bargo D, Mauri A, Marti-Vilalta JL: Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005;64:719-720.
21. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH: Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005;36:2497-2499.
22. Baumann CR, Baumgartner RW, Grandjour J, Von Bündingen HC, Siegel AM, Georgiadis D: Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke 2006;37:1332-1333.
23. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group: Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. Ann Emerg Med 2005;46:243-252.